These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18354269)

  • 1. Overexpression of orphan receptor tyrosine kinase Ror1 as a putative tumor-associated antigen in Iranian patients with acute lymphoblastic leukemia.
    Shabani M; Asgarian-Omran H; Jeddi-Tehrani M; Vossough P; Faranoush M; Sharifian RA; Toughe GR; Kordmahin M; Khoshnoodi J; Roohi A; Tavoosi N; Mellstedt H; Rabbani H; Shokri F
    Tumour Biol; 2007; 28(6):318-26. PubMed ID: 18354269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profile of orphan receptor tyrosine kinase (ROR1) and Wilms' tumor gene 1 (WT1) in different subsets of B-cell acute lymphoblastic leukemia.
    Shabani M; Asgarian-Omran H; Vossough P; Sharifian RA; Faranoush M; Ghragozlou S; Khoshnoodi J; Roohi A; Jeddi-Tehrani M; Mellstedt H; Rabbani H; Shokri F
    Leuk Lymphoma; 2008 Jul; 49(7):1360-7. PubMed ID: 18604725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of orphan receptor tyrosine kinase (ROR-1) expression in Egyptian pediatric acute lymphoblastic leukemia.
    Shaheen I; Ibrahim N
    Fetal Pediatr Pathol; 2012 Jun; 31(3):113-9. PubMed ID: 22369092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy.
    Daneshmanesh AH; Mikaelsson E; Jeddi-Tehrani M; Bayat AA; Ghods R; Ostadkarampour M; Akhondi M; Lagercrantz S; Larsson C; Osterborg A; Shokri F; Mellstedt H; Rabbani H
    Int J Cancer; 2008 Sep; 123(5):1190-5. PubMed ID: 18546292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia.
    Baskar S; Kwong KY; Hofer T; Levy JM; Kennedy MG; Lee E; Staudt LM; Wilson WH; Wiestner A; Rader C
    Clin Cancer Res; 2008 Jan; 14(2):396-404. PubMed ID: 18223214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL).
    Uhrmacher S; Schmidt C; Erdfelder F; Poll-Wolbeck SJ; Gehrke I; Hallek M; Kreuzer KA
    Leuk Res; 2011 Oct; 35(10):1360-6. PubMed ID: 21531460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies.
    Dave H; Anver MR; Butcher DO; Brown P; Khan J; Wayne AS; Baskar S; Rader C
    PLoS One; 2012; 7(12):e52655. PubMed ID: 23285131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROR1 is expressed on hematogones (non-neoplastic human B-lymphocyte precursors) and a minority of precursor-B acute lymphoblastic leukemia.
    Broome HE; Rassenti LZ; Wang HY; Meyer LM; Kipps TJ
    Leuk Res; 2011 Oct; 35(10):1390-4. PubMed ID: 21813176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies.
    Daneshmanesh AH; Porwit A; Hojjat-Farsangi M; Jeddi-Tehrani M; Tamm KP; Grandér D; Lehmann S; Norin S; Shokri F; Rabbani H; Mellstedt H; Österborg A
    Leuk Lymphoma; 2013 Apr; 54(4):843-50. PubMed ID: 22988987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative expression profile of orphan receptor tyrosine kinase ROR1 in Iranian patients with lymphoid and myeloid leukemias.
    Shabani M; Asgarian Omran H; Farsangi MH; Vossough P; Sharifian RA; Toughe GR; Razavi SM; Khoshnoodi J; Jeddi-Tehrani M; Rabbani H; Shokri F
    Avicenna J Med Biotechnol; 2011 Jul; 3(3):119-25. PubMed ID: 23408747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a.
    Fukuda T; Chen L; Endo T; Tang L; Lu D; Castro JE; Widhopf GF; Rassenti LZ; Cantwell MJ; Prussak CE; Carson DA; Kipps TJ
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3047-52. PubMed ID: 18287027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human neural tissues express a truncated Ror1 receptor tyrosine kinase, lacking both extracellular and transmembrane domains.
    Reddy UR; Phatak S; Pleasure D
    Oncogene; 1996 Oct; 13(7):1555-9. PubMed ID: 8875995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy.
    Hojjat-Farsangi M; Moshfegh A; Daneshmanesh AH; Khan AS; Mikaelsson E; Osterborg A; Mellstedt H
    Semin Cancer Biol; 2014 Dec; 29():21-31. PubMed ID: 25068995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
    Karvonen H; Perttilä R; Niininen W; Hautanen V; Barker H; Murumägi A; Heckman CA; Ungureanu D
    Oncogene; 2019 Apr; 38(17):3288-3300. PubMed ID: 30631148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
    Muñoz L; López O; Martino R; Brunet S; Bellido M; Rubiol E; Sierra J; Nomdedéu JF
    Haematologica; 2000 Jul; 85(7):704-10. PubMed ID: 10897122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy.
    Shabani M; Naseri J; Shokri F
    Expert Opin Ther Targets; 2015 Jul; 19(7):941-55. PubMed ID: 25835638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
    Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
    Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) cells.
    Hojjat-Farsangi M; Khan AS; Daneshmanesh AH; Moshfegh A; Sandin A; Mansouri L; Palma M; Lundin J; Österborg A; Mellstedt H
    PLoS One; 2013; 8(10):e78339. PubMed ID: 24205204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROR1 expression in mature B lymphoid neoplasms by flow cytometry.
    de Sousa FA; Millan NM; Correia RP; da Costa Vaz A; Schimidell D; Miyamoto PC; Passaro MS; Nogueira BG; Souto EX; Bacal NS; Bento LC
    Cytometry B Clin Cytom; 2024 Jan; 106(1):74-81. PubMed ID: 38273649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA; Fuller SG; Borowitz MJ
    Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.